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The public, its representatives in govern-, 
ment, and its practicing physicians have a 
well-known and well-documented interest 
in the opportunities and problems created 
by changes in drug therapy during the 
past twenty-five years. Their interest does 
not require further documentation here. 
The topic of the present report is the re-
sponse of academe to these opportunities, 
problems, and widespread interest. 
The most reliable list of American 
schools of medicine that have initiated 
programs in clinical pharmacology is, to 
my knowledge, the tabulation entitled 
Clinical Pharmacology Training Programs, 
made available in 1968 by the American 
Society for Pharmacology and Experimen-
tal Therapeutics. It is possible that a few 
medical schools with active training pro-
grams in clinical pharmacology were over-
looked for some reason when this list was 
drawn up, and the present report casts no 
disparagement on such schools, if they 
exist. But there is little doubt that the list 
is quantitatively the most reliable source 
available to anyone wishing to conduct 
a poll among clinical pharmacology 
groups in American schools at the present 
time. Therefore, in the Spring of 1969, I 
sent the following request for information 
to the director of each of the listed pro-
grams: 
"As Director of Clinical Pharmacology 
at your Medical School, you are in a bet-
ter position to know the status of teaching 
of clinical pharmacology and therapeutics 
to medical students than any other indi-
vidual working there. The Editorial Board 
of CLINICAL PHARMACOLOGY AND THERA-
PEUTICS has asked me to write a brief com-
mentary on the current status of teaching 
in this area; I would greatly appreciate 
your filling out the two lines at the bottom 
of this page and returning the answer to 
me in the enclosed envelope. I have tried 
to make this as brief as possible, and I 
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hope you will send me your reply by re-
turn mail." 
In further explanation of the question 
the following instruction was included: 
"The question here refers to medical 
students in all of the four years of medical 
school, but only to medical students. For 
simplicity, the hour is taken as the unit of 
teaching. A session is considered devoted 
to clinical pharmacology or therapeutics 
if it is primarily devoted to these subjects, 
even if a small amount of the time covers 
some other material. On the other hand, 
the usual phalmacology lecture or the 
usual diagnostically oriented medical staff 
conference or ward round presentation is 
not considered clinical pharmacology and 
therapeutics in this context, even if a small 
amount of clinical pharmacology and ther-
apeutics material is considered. The ques-
tion concerns all teaching of clinical 
pharmacology and therapeutics, however, 
whether done by you and your group or by 
others in the medical center. 
1. Accepting these admittedly rough defi-
nitions, how many hours of teaching in 
clinical pharmacology and therapeutics 
does the average medical student receive 
during the entire four years at your school? 
___ hours. 
2. Please indicate whether you consider 
this to be a precise figure , fairly 
precise estimate , only a rough esti-
mate " 
There are 3~) programs on the list. Re-
sponse was obtained from 32 directors (in-
cluding my own response for the program 
at the University of Michigan). Thus, the 
over-all response rate was 91 per cent. I 
submit that the data so obtained, though 
admittedly concise to the point of extreme 
simplicity, represent at least one piece of 
significant information regarding the teach-
ing of clinical pharmacology and thera-
peutics in American schools of medicine 
one-quarter century after the close of 
World War II initiated a period of 
pharmacologic expansion without parallel 
in history. 
According to the reports received, the 
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average medical student receives during 
his entire four years a mean of 31 hours 
of instruction in clinical pharmacology and 
therapeutics, the range being 0 to 100 
hours. The median is 22 hours. If these 
reports are representative of the situation 
throughout the United States, the teach-
ing of clinical pharmacology and therapeu-
tics in most schools of medicine in our 
country is an academic laugh-in. Most 
medical students receive fewer hours of 
teaching in clinical pharmacology and 
therapeutics than they receive in any sub-
sub-specialty, elective, or private project 
to which they are assigned for 3 full days 
during their entire four years of medical 
school. The course in clinical pharmacol-
ogy is a very short course indeed! 
It is first prudent to consider whether 
matters are really as bad as they seem. 
There are four possible bases for denying 
that the situation is all that serious: The 
schools polled may not be representative 
of all American medical schools; the indi-
viduals responding may have underesti-
mated the amount of information about 
clinical use of drugs that is given to stu-
dents in their respective schools; the "drug 
explosion" may be more cliche than fact, 
thereby rendering it unnecessary to give 
much instruction in the clinical use of 
drugs; or, finally, students may learn a 
great deal about subjects that are not pre-
sented during any formal hours of instruc-
tion, and the counting of such formal hours 
may therefore be irrelevant. I shall discuss 
these possibilities in the order presented. 
It is certainly possible that the respond-
ents, representing roughly one third of the 
American medical schools, are not repre-
sentative of the entire picture in this coun-
try. In fact, it is very likely that they are 
not representative. For the other two 
thirds of the schools are probably in 
even worse condition! Although it is 
conceivable that schools having train-
ing programs in clinical pharmacology 
may use them as a form of tokenism and 
may thereby be less interested in the 
teaching of clinical pharmacology than 
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other schools, this possibility seems to me 
remote and the suggestion appears to de-
pend on a rather twisted argument. We 
live in an era in which the teaching of 
advanced students, such as the selected 
physicians who participate in most post-
graduate training programs in clinical 
pharmacology, has acquired considerable 
prestige; schools that do not conduct such 
programs for advanced trainees are prob-
ably neglecting the teaching of clinical 
pharmacology to their medical students 
even more than schools that do have such 
training programs. Individual exceptions 
very probably exist and merit applause 
wherever they may be found. But the over-
whelming probability is that schools which 
have not seen fit to initiate training pro-
grams in clinical pharmacology give even 
less instruction to medical students in the 
clinical use of drugs than those schools 
represented in the present survey. 
The possibility of inaccuracy in the re-
sponse merits more serious consideration. 
Twelve of the respondents stated that 
their figures were "only a rough estimate," 
13 felt that they gave a "fairly precise 
estimate," and only 7 flatly stated that they 
were giving a "preCise figure." Moreover, 
as one respondent pointed out, the request 
that time devoted to teaching of "thera-
peutics" be added to that devoted to 
"clinical pharmacology" makes it more dif-
ficult to give a really precise estimate. But 
clinical pharmacologists still form a suffi-
ciently small circle to permit most of those 
engaged in the work to know almost every-
one else in the field. Most of the respon-
dents are personally known to me; they 
are careful and conscientious men who 
are intensely interested in this area. They 
are also in a better position to give an an-
swer to the question asked than anyone 
else in their schools. Therefore, although 
the data are subject to the softness in-
herent in any data furnished by a single 
individual for each school, I believe they 
are the best data one can get without re-
sorting to a cumbersome mobilization of 
academic bureaucracy, with the full 
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panoply of lengthy questionnaires, pro-
tracted arguments about definitions, and 
other such delights. 
The third possibility, i.e., that the gener-
al concern about physicians' use of drugs 
may be an exaggerated concern is, I be-
lieve, untenable and I mention it here only 
for the sake of completeness. The fact that 
many groups outside medical schools are 
interested in something would not of itself 
mean that their interest is justified. But the 
justification comes from the widespread 
use, importance, and power of modem 
drugs. The recent review of the efficacy 
and safety of a large number of drugs by 
a distinguished group of national commit-
tees has very clearly shown that physicians 
have available to them a broad series of 
potent compounds, for good and for ill. 
They also have available other drugs 
which, by their very popularity, suggest 
that their physician users should have been 
better instructed. Studies such as those of 
Dr. Leighton Cluff and his associates have 
thoroughly established the large number 
and variety of drugs administered to the 
usual hospital patient. (I do not suggest 
that increased knowledge of drugs would 
expand this use even further. On the con-
trary, increased teaching in this area 
would probably slim down the fat list of 
drugs presently prescribed, and this in 
itself would be no mean accomplishment.) 
Interaction among drugs has moved from 
laboratory theory to ward and outpatient 
fact. And the need for additional teach-
ing in clinical pharmacology is supported 
by important examining bodies. For ex-
ample, a review of the 51 self-assessment 
questions for internists published in the 
highly reputable AntUlls of Internal Medi-
cine over a 12 month period from Sep-
tember, 1968, to August, 1969, shows that 
approximately 40 per cent of the questions 
were concerned, wholly or in part, with 
therapeutic or adverse effects of drugs; 
25 per cent of the entire list were ques-
tions that involved drugs as their primary 
concern. 
Finally, the ability of medical students 
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to learn many things that are not given 
during formal class hours is, Deo gratWs, 
an important consideration. Students can 
be, and doubtless often are, stimulated to 
make their own synthesis of information 
obtained in basic pharmacology courses 
and practical experience obtained during 
clinical clerkships with the use of such 
methods as additional reading, off-hour 
discussions, etc.. The ability of some stu-
dents to survive bad teaching practices in 
medical schools has often been noted. But 
it is no excuse for the continuation of such 
practices. Also, of course, there are many 
excellent clinical pharmacologists in institu-
tions other than schools of medicine. The 
National Institutes of Health provide out-
standing examples, and the pharmaceuti-
cal industry has its share. But medical 
schools and medical schools alone provide 
the primary training of physicians. When-
ever medical schools fail to teach their 
students important principles and facts in 
some area of medicine, this information 
does not get imprinted into the primary 
mental matrix of the developing physician. 
Subsequent teaching can do much; in-
deed, I have used the existence of post-
graduate teaching programs as one point 
in favor of certain medical schools in the 
opening paragraphs of this commentary. 
But the importance of postdoctoral train-
ing does not cancel out the principle under 
discussion now. If one wishes to assure 
that all physicians receive thorough 
grounding in some important area, that 
area must be taught extensively in medical 
schools. 
While preparing this commentary, I took 
part in the oral examination of three senior 
medical students who had just completed 
a clinical period. They had been assigned 
to me at random for oral examination. It 
is important to note here that we have for 
many years been very fortunate in getting 
medical students of high intellectual cali-
ber at the University of Michigan, as have 
many other medical schools, and at least 
two of the three students examined seemed 
basically to be rather bright people. Yet, 
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among the three students examined, the 
following ideas were unearthed by ques-
tioning: A daily dose of 10,000 units of 
penicillin is the indicated dose in the treat-
ment of pneumonia caused by a gram-
positive organism ( admittedly, this just 
might work against the pneumococcus, 
but I doubt that anyone would recom-
mend it as the usual regimen); streptomy-
cin given alone was mentioned as a rea-
sonable treatment for subacute bacterial 
endocarditis caused by Streptococcus 
viridans, a suggestion that possibly de-
rived from the poetic lilt of "streptomycin 
for streptococcus"; sulfonamides are a 
common cause of the nephrotiC syndrome; 
it is incorrect to use a loading dose when 
digitalizing a patient. In addition to this 
torrent of misinformation, one student was 
aware that "thorazine" is a tranquilizing 
agent but could not even name the class 
of drug to which this agent belongs. One 
did not know that colchicine frequently 
causes diarrhea as a major adverse effect 
(heaven help his first gouty patient as the 
dosage mounts). Finally, whereas one of 
the three was confused about the proper 
method of digitalizing a patient, the other 
two (senior medical students, mind you) 
had no idea whatsoever about the digitali-
zation of a patient and did not even at-
tempt to answer that question. Again, let 
me stress that these were not three 
flunkers undergoing make-up examination 
but three students assigned at random 
during oral examination period, drawn 
from a class of individuals who are funda-
mentally bright people. 
As I reflect on this dismal experience, 
certain points come to mind. First, there 
is little consolation in the fact that many 
of the questions happened to involve areas 
for which I do not have personal teaching 
responsibility. The time devoted to the 
teaching of clinical pharmacology and 
therapeutics is so brief that I would hesi-
tate to suggest any better results if the 
students had been questioned about areas 
for which I do have more teaching re-
sponsibility. Second, it seems likely that 
Vulume 11 
Number 4 
the present situation is often underreported 
because of an easily understandable reluc-
tance on the part of those who are aware 
of it; the first reaction of others may be 
the same as my first reaction, to be almost 
ashamed to report the facts. Third, the 
needlessness of the present situation is 
particularly frustrating. Virtually everyone 
who enters the area of clinical pharmacol-
ogy does so because of strong interest in 
teaching as well as research. Moreover, a 
school is very unlikely to get a clinical 
pharmacology program unless the clinical 
pharmacologist has the support of his dean, 
the chairman of the department of phar-
macology, and the chairman of a major 
clinical department (most often, internal 
medicine). These influential men must 
have decided to promote a clinical phar-
macology program in their schools and 
must have accepted the credentials of 
their clinical pharmacology staff, after 
close scrutiny, or there would be no such 
program in existence in their schools. Ad-
mittedly, some programs began with the 
enthusiastic support of two of the three 
major individuals mentioned above, but 
most of us have had the good fortune to 
have all three supporting us or we would 
not have been able to begin. The reflex 
tendency to blame the higher echelons 
of medical education, deans and depart-
ment chairmen, for the problem discussed 
here is probably in error; the opposition to 
improved teaching of clinical pharmacol-
ogy and therapeutics probably comes from 
the middle echelon of academe. When bat-
tles are being lost, the top generals are 
usually more than willing to consider 
changes in strategy. The difficulty comes 
in getting top sergeants to change their 
ways. As for the teaching qualifications of 
the clinical pharmacologists in the various 
schools, the recent expansion in the num-
ber of these programs seems to me to have 
in no way diluted the quality of the pro-
grams. The teachers who have begun clini-
cal pharmacology programs in the last few 
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years have had better training and better 
qualifications than· I had when I began a 
clinical pharmacology program. 
As to the students, I do not believe 
that I am being naive in saying that we 
still attract a goodly number of students 
who enter medical schools with high mo-
tivation as well as appropriate intellectual 
qualifications. For I also had a session 
with the entire second year pharmacology 
class, early in their course, during the 
time of preparation of this commentary. 
This session was quite informal, with many 
questions from the student audience. The 
questions were almost uniformly of high 
caliber, reflecting a surprising amount of 
maturity, thoughtfulness, and good sense. 
Medical schools may yet fall into decay 
by attracting the type of student who 
comes to school to riot and grab power, 
and it will then be hopeless to try to teach 
anything to such students; but we cannot 
invoke this excuse for the teaching failure 
that has occurred thus far. 
What about the regular staff members 
who are in charge of teaching basic phar-
macology? They are in some instances 
friendly and in some instances cool toward 
the teaching of clinical pharmacology, but 
they are beset by their own troubles, in 
any event. For some schools have taken 
the surrealist position that the appropriate 
response to a need for more teaching about 
drugs is to gut their own pharmacology 
departments. If this move succeeds, it will 
usher in a new Ice Age in drug therapy, 
and God only knows what a bleak moraine 
will be left at its end. 
Finally, any curriculum reform that con-
sists in mere swapping of instruction hours 
between one year of medical school and 
another, in an atmosphere of academic 
horse trading, will solve very little. 
How far, then, has academe really risen 
to meet the challenge posed by advances 
in pharn1acology and therapeutics? Ap-
parently, it has risen about one Angstrom 
unit. 
